Nanoparticle targeted drug delivery system
-
Upload
bindiya-patel -
Category
Health & Medicine
-
view
212 -
download
8
description
Transcript of Nanoparticle targeted drug delivery system
![Page 1: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/1.jpg)
NANOPARTICLES
Presented By Bindiya Patel
M.PHARM (PHARMACEUTICS)
![Page 2: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/2.jpg)
2
CONTENTS1. INTRODUCTION2. CONCEPT3. ADV AND DISADV4. IDEAL CHARACTERISTICS5. METHOD OF PREPARATION6. CHARACTERIZATION7. EVALUATION8. APPLICATIONS
![Page 3: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/3.jpg)
3
INTRODUCTION
» DEFINITION:
» Nanoparticles are subnanosized colloidal drug delivery systems
» particle size ranges from 10-1000 nm in diameter.
» They are composed of synthetic or semi synthetic polymers carrying drugs or proteinaceous substances, i.e. antigen(s).
» Drugs are entrapped in the polymer matrix particulates or solid solutions or may be bound to particle surface by physical adsorption or in chemical form.
![Page 4: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/4.jpg)
4
CONCEPT» The basic Concept involved is :
» Selective and Effective Localization of pharmacologically active moiety at preselected target(s) in therapeutic concentration,,
» Provided restriction of it’s access to non-target normal tissues and cells.
» Nanoparticles are mainly taken by : Reticulo Endothelial System (RES), After the administration;
![Page 5: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/5.jpg)
5
» Hence are useful to carry drugs to the liver and to cells that are phagocytically active.
» By modifying the surface characteristics of the nanoparticles it is possible to enhance the delivery of drugs to spleen relative to the liver.
» Distribution of the nanoparticles in the body may be achieved possibly by :
» Coating of nanoparticles with certain Serum components, Attachment of antibodies or sulfoxide groups and the use of Magnetic nanoparticles.
![Page 6: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/6.jpg)
6
ADVANTAGES » Reduction in the frequency of the dosages
taken by the patient» More uniform effect of the drug» Reduction of drug Side Effects» Reduced fluctuation in circulating drug levels» Avoids hepatic first pass metabolism
![Page 7: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/7.jpg)
7
DISADVANTAGES
» High cost» Productivity more difficult» Reduced ability to adjust the dose» Highly sophisticated technology» Requires skills to manufacture» Difficult to maintain stability of dosage form. E.g.: Resealed erythrocytes stored at 40C.
![Page 8: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/8.jpg)
8
IDEAL CHARACTERISTICS» It should be biochemical inert , non toxic and
non-immunogenic.
» It should be stable both physically and chemically in Invivo & invitro conditions.
» Restrict drug distribution to non-target cells or tissues or organs & should have uniform distribution.
» Controllable & Predicate rate of drug release.
![Page 9: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/9.jpg)
9
» Drug release should not effect drug action
» Specific Therapeutic amount of drug release must be possessed
» Carriers used must be biodegradable or readily eliminated from the body without any problem and no carrier induced modulation in disease state.
» The preparation of the delivery system should be easy or reasonable
» simple, reproducible & cost effective.
![Page 10: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/10.jpg)
10
Method of preparation
A : Cross Linking Methods » 1) By Cross-linking of Amphiphilic Macromolecules» 2) By Crosslinking in W/O Emulsion» 3) By Emulsion chemical dehydration» 4) By Phase Separation » 5) By pH lnduced Aggregation
B : Polymerization Methods
» 1) Emulsion polymerization» 2) Dispersion polymerization
![Page 11: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/11.jpg)
11
1) By Cross-linking of Amphiphilic Macromolecules» Nanoparticles can be prepared from Amphiphilic macromolecules,
proteins and polysaccharides (which have affinity for aqueous and lipid solvents).
» The method involves Aggregation of Amphiphiles followed by stabilization either by heat denaturation or chemical cross-linking
2) By Cross linking in W/O Emulsion
» Emulsification of bovine serum albumin (BSA) OR human serum albumin (HSA) or protein aqueous solution in oil using high-pressure homogenization or high frequency sonication.
![Page 12: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/12.jpg)
12
Aqueous protein (BSA)
Oil
W/O emulsion
Dilution with preheated oil (100oC)(Heat cross-linking) Or Addition of crosslinking agent(Chemical cross-linking)
Centrifugation and isolation of nanoparticles
Emulsification using high-pressure homogenization or high frequency sonication
Surfactant
![Page 13: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/13.jpg)
13
3) Emulsion Chemical Dehydration
» Stabilization can also be achieved by emulsion chemical dehydration.
» Hydroxy propyl cellulose solution in chloroform is used as a continuous phase,
» while a chemical dehydrating agent, » 2,2, di-methyl propane is used to disperse into the
internal aqueous phase to form an Emulsion.
» ADV: The method avoid coalescence of droplets and could produce nanoparticles of smaller size (300nm),
![Page 14: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/14.jpg)
14
4) Phase seperation
» The protein or polysaccharide from an aqueous phase can be Desolvated by :˃ A) pH change ˃ B) Change in temperature ˃ C) Addition of appropriate counter ions e.g. alginate
![Page 15: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/15.jpg)
Aqueous phase(protein aqueous solution)
Protein aggregates (Coacervates)
Protein colloidal dispersion
Nanoparticles dispersion (External aqueous phase) 200nm
Desolvation
Resolvation
Cross-linking
Heat to 40o C , subsequent cooling to 4O C for 24h.
15
![Page 16: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/16.jpg)
16
5) pH lnduced Aggregation
» Gelatin Nanospheres were prepared by : Gelatin & tween 20 were dissolved in aq. phase & pH
of the solution was adjusted to optimum value. The clear solution so obtained was heated to 400C
followed by its quenching at 40C for 24hrs & subsequently left at ambient temperature for 48hrs.
The sequential temperature treatment resulted into a colloidal dispersion of aggregated gelatin. The aggregates were finally cross linked using glutaraldehyde as cross linking agent the optimum pH was 5.5- 6.5.values
below 5.5 produced no aggregation while above 6.5 an uncontrolled aggregation led to the formation of larger nanospheres
![Page 17: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/17.jpg)
17
Polymerization based methods
1) Emulsion polymerization :
» IT CONSISTS OF :
» A] Micellar nucleation and polymerization :
Monomer is insoluble in continuous phase.(O/W phase)
Aqueous phase
» B] Homogenous nucleation and polymerization :
Monomer is soluble in continuous phase.(W/O phase)
Organic phase.
![Page 18: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/18.jpg)
18Monomer bearing Nucleated micelle Stabilized polymeric micelle nanospheres
Catalyst
Monomer dropletCatalystDrug Monomer
monomer supply
(micelle) (nanospheres)
Micellar nucleation and polymerization
![Page 19: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/19.jpg)
19
Homogenous nucleation and polymerization
![Page 20: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/20.jpg)
2] Dispersion polymerization
lsolation of nanospheres
Oligomers aggregate & precipitates
Further, By chemical initiation
(ammonium or potassium per oxo disulphate)
(Acrylamide or Methyl methacrylate) Monomer is dissolved
in an aqueous medium
Heated to above 65 C
20
![Page 21: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/21.jpg)
Solvent Evaporation Method
![Page 22: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/22.jpg)
Solvent Displacement Method
![Page 23: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/23.jpg)
23Salting out of Polymer
![Page 24: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/24.jpg)
24
Characterization and evaluation of nanopatricles
PARAMETER METHOD
1) Particle size - Photon correlation spectroscopy
- Laser defractometry - Scanning electron
microscopy
2) Molecular weight - Gel Chromatography
3) Charge determination - Laser Doppler Anemometry
- Zeta potentiometer
![Page 25: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/25.jpg)
25
4) Density - Helium compression pynometry
5) Crystallinity - X-ray diffraction & Differential scanning Calorimetry, Thermogravimetry
6) Hydrophobicity - Hydrophobic interaction, Chromatography
7) Surface element analysis - X-ray, photon electron
![Page 26: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/26.jpg)
26
8) Specific Surface Area :
specific surface area A = 6/Density x diameter of particle
9) Invitro Release : > Diffusion Cell . > Recently Introduced Modified Ultra Filtration Technique. > Media Used : Phosphate Buffer
10) Nanoparticle Yield : % yield = Actual weight of Product X 100
Total weight of Drug and Excipients
![Page 27: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/27.jpg)
27
Applications
1) Widely used in case of Cancer Therapy.2) In lntracellular Targeting3) Used for Prolonged Systemic Circulation.4) As a Vaccine Adjuvant.5) In Case of Ocular delivery.6) Used in DNA Delivery.7) It is used in case of Oligonucleotide delivery.8) Enzyme immunoassays9) Radio-imaging.10) To cross BBB.
![Page 28: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/28.jpg)
28
» ApplicationsApplication Purpose Material
Cancer therapy Targeting, Reduced toxicity, enhance uptake of anti-tumor agent
Polyalkylcyanoacrylate with anticancer agent
Intra cellular targeting Target reticuloendothelial system for intracellular infection
Poly alkyl cyanoarylate
Vaccine adjuvant Prolong systemic drug effect. Enhance immune response
Poly methyl metha acrylate nanoparticles with vaccines
DNA delivery Enhanced bioavailability and significantly higher expression level
DNA gelatin nanoparticles, DNA chitosan nanoparticles
Ocular delivery Improved retention of the drug and reduced washed out.
Poly alkyl cyanoacrylate nanoparticles , anti-inflammatory agent
![Page 29: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/29.jpg)
29
![Page 30: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/30.jpg)
30
REFERENCE
» Targetted and controlled drug delivery by S.P. VYAS and R.K. KHAR
» Jain N.K. “Advances in controlled and novel Drug Delivery”, CBS publisher & Distributers, Edition 1st 2001, Pg. 408
» Nanotechnology in drug delivery - A Review, Indian Drugs, Issue 11,november 2011.
» http://en.wikipedia.org/wiki/Nanoparticle» http://www.pharmainfo.net/reviews/nanoparticles-review
![Page 31: Nanoparticle targeted drug delivery system](https://reader033.fdocuments.in/reader033/viewer/2022052201/548c8480b479594e508b49b1/html5/thumbnails/31.jpg)
31